Mike Fitzpatrick

Mike Fitzpatrick

PENNSYLVANIA's 8th DISTRICT

Lawmakers Hail Commitment on Health Screenings

2016/06/16

Washington, D.C. – Congressmen Patrick Meehan (R/PA-07), Brendan Boyle (D/PA-13) and Mike Fitzpatrick (R/PA-08) today secured a commitment from the chairman of the House’s defense spending panel to work with the lawmakers and the state of Pennsylvania to address the need for health screenings in communities surrounding the former Naval Air Station-Joint Reserve Base at Willow Grove and the former Naval Air Warfare Center in Warminster.

Rep. Rodney Frelinghuysen (R/NJ-11), Chairman of the House Appropriations Committee’s Defense Subcommittee, pledged to work with the lawmakers and Pennsylvania’s government on the issue during debate on an annual defense spending bill. Frelinghuysen indicated that measures taken in Pennsylvania could be used as a national model for addressing similar groundwater contamination issues near former military installations.

In addressing Meehan during the floor debate, Frelinghuysen said, “Our committee is certainly committed to working with him and thank him for his leadership and we’ll be working very closely with him and with the state of Pennsylvania to see what sort of partnerships we can put together to address this problem,” Frelinghuysen said. “What might be a success in Pennsylvania could look [to be used] across the nation for implementation as well.”

“Make no mistake: the federal government is responsible for this water contamination,” said Congressman Meehan. “We owe it to the Pennsylvania families and communities affected to cover the cost of needed health screenings…The Navy deserves credit for being proactive on this issue. But we’ve held private companies responsible for industrial contamination of groundwater wells. We should hold the Navy to the same standard,” Meehan said. “I’m grateful for the Chairman’s commitment to addressing this issue and I’m grateful for the continued bipartisan work on it with my colleagues Brendan Boyle and Mike Fitzpatrick.”

“Our community is seeking information regarding their years – decades – of past exposure to these chemicals at the hands of our military,” said Congressman Boyle. “We must help affected residents make informed health decisions…. The federal government must fulfil its obligation to these communities, and we all must pay closer attention to this growing issue,” said Boyle. “I appreciate the Chairman and Ranking Member’s commitment to working with us to push the DOD to fulfill its responsibilities.”

"The Department of Defense has begun the process of checking whether chemical compounds like PFOS and PFOA may have contaminated groundwater surrounding more than 660 military sites across the nation, including confirmed contamination around the former Naval Air Warfare Center in Warminster and former Willow Grove Naval Station in Horsham. In each of these instances, both public and private wells in my district have been impacted by contaminated groundwater – rightly concerning residents and local leaders," said Fitzpatrick. "Because of this immediate and widespread concern, it is only right that the Department of Defense increase efforts to offer health screenings in communities surrounding these formerly used defense sites.  Congress must work together to reaffirm this government’s commitment to protecting the health and safety of its citizens."

The lawmakers have worked closely together since the discovery of chemical compounds PFOA and PFOS in the groundwater surrounding the former military installations in Montgomery and Bucks Counties.

 

Read More

Fitzpatrick Statement on Orlando Terrorist Attack

2016/06/13

LANGHORNE, PA – Congressman Mike Fitzpatrick (PA-8), chairman of the bipartisan Task Force to Combat Terrorism Financing, released the following statement regarding the terror attack in Orlando, Florida:

James Clapper warned that we must be prepared and vigilant for the possibility that ISIS will infiltrate our country.  As we continue to grieve and pray for those devastated by this attack, we must redouble our efforts and be clear in our resolve to protect our nation and her citizens from the radical Islamic terrorism that continues to target us. This fight must be carried out on multiple fronts: through diplomatic action, addressing terror financing and, when appropriate, the use of military force. We must never lose sight of the challenges we face nor the capacity, as Americans, to address them.”

Speaker Paul Ryan ordered that flags at the U.S. Capitol be flown at half-staff in honor of the victims.

###

Read More

Fitzpatrick Questions FDA About Essure Reporting

2016/04/19

WASHINGTON, D.C. – Congressman Mike Fitzpatrick (PA-8) sent the following letter to the Food and Drug Administration Tuesday regarding dramatic changes in the reporting of adverse events caused by the medical device Essure:

Dear Dr. Shuren,

Information has been brought to my attention that shows a dramatic change in how Adverse Event Reports relating to the permanent sterilization device Essure were submitted to the FDA coinciding with the agency’s announcement that it was reviewing the safety of the device.

As you know, when a manufacturer submits an Adverse Event Report to the FDA one of the data fields to be filled is “Reporter Occupation.” Examples of how that field can be coded by the manufacturer include “Physician,” “Health Professional,” “Nurse,” “Pharmacist,” “Paramedic,” “Risk Manager,” and “Other.”

As it relates to Essure, from January 2002 through June 2015, the manufacturer of the device submitted nearly 600 Adverse Event Reports in which the “Reporter Occupation” field was coded as “Physician.” This corresponds to the narrative information included in the report in which it clearly states the information in the report came from a medical doctor, a Gynecologist/ Obstetrician, a physician, or other similar term.

However, this coding changed dramatically in July 2015. I find this extremely concerning given the fact that on July 17, 2015, the FDA announced it was reviewing the safety and effectiveness of the Essure device.

After the FDA’s public announcement, Adverse Event Reports received by the agency from the manufacturer of Essure no longer coded reports from medical doctors as Physician reports. Instead, almost every report received from a physician between August 2015 and February 2016 listed the Reporter Occupation field as “Other.” This is a clear change from how the manufacturer coded prior to FDA’s announcement despite the same keywords, like medical doctor or Ob/Gyn, being found in the narrative portion of the reports. A similar change was noted in reports received from nurses.

I respectfully request the FDA to review the Adverse Event Reports from physicians and provide answers the following questions:

1.       Did the FDA request the manufacturer to change how it was coding physician reports?

2.       If the FDA did not request this change, is there a legitimate basis by which a manufacturer would suddenly change how they code reports from medical doctors and Ob/Gyns and code the occupation as “Other” instead of as “Physician”?

3.       Was the FDA aware of this change?

4.       Did the manufacturer of Essure notify the FDA it was changing how it reported the Report Occupation field within the Adverse Event Reports?

5.       Was the FDA aware of this change prior to the September 24, 2015 Advisory Committee meeting related to Essure?

6.       Does the FDA review Adverse Event Reports with the Reporter Occupation field coded as “Physician” differently than reports coded as “Other?” Are “Physician” reports given more weight when FDA is reviewing Adverse Event Reports than reports coded as “Other?” If so, please describe the differences in how the FDA reviews a report received from a physician compared to other types of reports.

7.       If the FDA were to generate a list of Adverse Event Reports received from “Physicians” about Essure, would reports coded as “Other” be included? If the Reporter Occupation is listed as “Other,” does the FDA conduct additional analysis of the narrative portion of the report to determine if the report came from a medical doctor?

8.       Is it illegal for a manufacturer to knowingly manipulate data listed on an Adverse Event Report?

9.       What are the penalties for knowingly submitting false information to the FDA in an Adverse Event Report?

10.   Has the FDA ever held a manufacturer accountable for falsifying or intentionally miscoding information submitted in an Adverse Event Report?

I appreciate your prompt attention to this request. Should you have any questions, please do not hesitate to contact Justin Rusk on my staff.

Sincerely,

Read More

Fitzpatrick Letter to Vice President Urges Power Morcellator Review in ‘Cancer Moonshot’ Initiative

2016/04/15

WASHINGTON, D.C. – Congressman Mike Fitzpatrick (PA-8) Wednesday called on Vice President Joseph Biden to take action on reforming medical device review and monitoring processes as part of the Administration’s “Cancer Moonshot” initiative – specifically highlighting power morcellators. 

“As part of the Cancer Moonshot, we have the chance to protect others from the harm caused by dangerous medical devices. In 2016 there will be an estimated 595,690 cancer deaths in the United States. We must guard against unsafe medical devices from contributing to those staggering statistics,” wrote Fitzpatrick. “While supporting the development of new devices to target cancer, we must ensure that the FDA is able to review, monitor, and quickly take action should those devices do harm. Unfortunately, we are too late for many women who, because of morcellation, were not given a fair chance to fight and beat their cancer. But we have a chance to protect others.”

The complete letter is below:

Dear Vice President Biden,

I applaud your efforts as part of the cancer Moonshot program to make cancer a thing of the past. This program will have life changing effects on the more than 14 million people living with cancer in the United States.

As part of the Cancer Moonshot, President Obama called for the development of a virtual Oncology Center of Excellence within the Food and Drug Administration (FDA). The purpose of the center is to “support the continued development of companion diagnostic tests, and the use of combinations of drugs, biologics and devices to treat cancer.” While it is critically important we support the development of innovative new devices and drugs to treat cancer, it is just as important to take this opportunity to implement meaningful reforms to make medical devices safe.  Unfortunately, for decades, a medical device known as a laparoscopic power morcellator proved tragically unsafe, spread cancer throughout the body of those it was designed to help, and led to the death of hundreds, if not thousands, of women.

Power morcellators are FDA-cleared medical devices that are used to remove uterine fibroids. The blades of this device shred the uterine fibroids, which are then removed through a laparoscopic incision. For over two decades, morcellation was marketed as a safe, routine procedure. However, if a uterine fibroid is harboring an undetectable cancer, the morcellation of that cancerous tissue and its removal through the abdominal cavity can spread that cancer throughout a woman’s body. This device can take a Stage 1 treatable cancer immediately to a Stage 4 terminal cancer. And tragically for too many women, this routine procedure ended with a death sentence.

Although the risk of spreading unsuspected cancers in women is as high as 1 in 352 cases, for decades the device stayed on the market, and it was only in November 2014 that the FDA put a black box warning on the device. It took a victim of morcellation and mother of 6, Dr. Amy Reed, to get the FDA take notice. It took the families of those who lost mothers, sisters, and wives, and those who continue to battle the cancer spread by morcellation, to get the FDA to take action.

As part of the Cancer Moonshot, we have the chance to protect others from the harm caused by dangerous medical devices. In 2016 there will be an estimated 595,690 cancer deaths in the United States. We must guard against unsafe medical devices from contributing to those staggering statistics. While supporting the development of new devices to target cancer, we must ensure that the FDA is able to review, monitor, and quickly take action should those devices do harm. Unfortunately, we are too late for many women who, because of morcellation, were not given a fair chance to fight and beat their cancer. But we have a chance to protect others. We must take action.

There are simple steps we can take today to improve patient safety for tomorrow’s beneficiaries of innovative new devices. One simple way we can do this is to ensure that serious injuries and deaths caused by medical devices are promptly reported to the FDA. For years there was evidence that morcellation was spreading cancer in women. But those reports never made it to the FDA. For years women were dying from the cancer spread by this device. But their deaths were never reported to the FDA by the hospitals, the device manufacturers, or the doctors who were charged with their care.

This was despite federal requirements that FDA be informed about unsafe devices. We must do more to strengthen medical device reporting regulations to ensure that dangerous devices, like the morcellator that spread cancer in women for decades, are quickly identified and removed from the market before they can do more harm.

I applaud your leadership on this important mission that will undoubtedly save lives, and look forward to continuing to work with you to help eliminate cancer as we know it.

Please do not hesitate to contact me if I may be of assistance.

Sincerely,

Read More

Fitzpatrick Responds to Administration’s Fiduciary Rule

2016/04/07

WASHINGTON, DC – Congressman Mike Fitzpatrick (PA-8), a member of the House Financial Services Committee, released the following statement regarding the Department of Labor’s release of its finalized fiduciary rule:

“While I share the Administration’s concerns to protect retirees and individuals planning for their retirement, I have serious concerns that this rule will have the unintended consequence of placing quality and affordable financial advice out of reach for the millions of American families that need it most. It is important that elected officials carefully review this new rule to ensure investors are receiving the best advice and small businesses are spending more time advising their customers rather than complying with new Washington mandated regulations.”

Background

During five hearings and a markup on the proposed rule, the Financial Services Committee learned:

  • The supposed basis of the Department of Labor’s proposal -- that investors are losing $17 billion a year due to conflicts of interest -- does not withstand even minimal analytical scrutiny.  There is no study that directly supports this estimate, and it appears to be based upon generalizations and extrapolations that are not fully supported by empirical data.

"The calculations underlying these numbers misinterpret and incorrectly apply the findings of the very same academic research cited as the foundation of the claims, and do not consider the significant harm to retirement savers that is sure to result if the Department adopts the rules as currently drafted.  In fact, these assertions do not stand up when tested against actual experience and data.” - Paul Schott Stevens, President and CEO of the Investment Company Institute

  • The Department of Labor’s Regulatory Impact Analysis also appears to have omitted the costs of the loss of financial advice to investors.  Even the Department of Labor itself, in a 2011 report, estimated that consumers who invest without professional advice make investment errors that collectively cost them $114 billion per year – far exceeding the purported benefit of the ruleUsing the Labor Department’s own report, implementing a rule that could limit access to financial advice would create costs that far exceed its presumed benefits.
  • The United Kingdom (UK) implemented a similar rule for “conflicted financial advice” in 2013.  Within two years, the rule had created an advice gap in which 60,000 investors were unable to receive financial advice. As a result, the UK’s government initiated a review of the extent to which financial advice for smaller investors is being diminished by the rule.
  • A report from Cass Consulting on the impact of the UK’s initiative noted that it has left aside those “who have too few assets to merit attention from professional advisers, though they may well be in need of financial advice. This cannot be a desirable outcome.”
  • The SEC, not the Department of Labor, is the expert financial advice regulator.  Congress designated the SEC to oversee and regulate the conduct of persons providing investment advice and effecting securities transactions in the United States.
  • While Labor Secretary Perez testified in June 2015 that the Department of Labor has coordinated with the SEC in the development of the proposed rule, there appears to be disagreement about the level of actual coordination.  For example, SEC Commissioner Daniel Gallagher stated in his comment letter to the proposal that he was not included in any conversations.  Commissioner Gallagher further commented that, “[f]rom a distance ‐‐ a place where a presidentially‐appointed SEC Commissioner should not be in this context ‐‐ it appears that any interaction between staffs at DOL and the SEC and all of these discussions with Chair White have borne no fruit.”
  • The Department of Labor’s rule does not contemplate or even mention potential SEC rules or the SEC's existing regime for regulating broker-dealers and investment advisers.

“Securities and Exchange Commission Chairwoman Mary Jo White told lawmakers Tuesday that if the agency proposes a rule to raise retail investment advice standards, it may not mesh perfectly with a separate Labor Department rule that will soon be finalized.”

  • The Department of Labor’s rule will disproportionately impact low and middle income families striving to save for retirement.

“First and foremost, we continue to be very concerned that the DOL has proposed a rule that will severely restrict African Americans’ and low- to moderate-income Americans’ ability to save for retirement.  The new regulations also will make it more difficult for our members – as small business owners – to sponsor retirement savings plans for themselves and for the benefit of their employees.” – National Black Chamber of Commerce

“As a result of the proposed rule, African American families will have less opportunity to achieve their retirement goals because the lower-cost commission-based services they benefit from today will no longer be available for IRAs." – Ivan Earle, Chairman of Primerica’s African American Leadership Council

###

Congressman Mike Fitzpatrick is serving his fourth term in the U.S. House of Representatives. He represents Pennsylvania’s 8th district which includes all of Bucks County as well as a portion of Montgomery County. He serves as the Vice Chairman of the House Financial Services Subcommittee on Oversight and Investigations.

Read More

Fitzpatrick Statement on Release of FDA’s Essure Review

2016/02/29

LANGHORNE, PA – Congressman Mike Fitzpatrick (PA-8) released the following statement Monday regarding the announcement of the Food and Drug Administration’s five-month review of the permanent sterilization device Essure:

“It’s unbelievable that it took the FDA since September to make just two recommendations with no enforcement measures and ask the manufacturer to perform another study while leaving Essure on the market.

Frankly, I’d contend that the 25,000 women harmed by Essure are the postmarket study that FDA is ordering. It’s been done. The evidence is all there: Tens of thousands of injured women and hundreds of fetal deaths. As my constituent, Dr. Amy Reed, a victim of unsafe devices herself, testified at the FDA in September, ‘[w]e don’t need to hurt any more women.’ If the FDA is going to order another study, then at minimum they should take Essure off the market during that time. A 60 day comment period and another study while this device remains on that market only guarantees more women harmed.

Because the FDA is failing to act, I believe Congress must. That’s why, moving forward, I will advocate for a number of legislative actions to address this issue, including:

  • Continuing my call for the House and Senate to take up and pass the E-Free Act to revoke the FDA approval of Essure;
  • Working to block government agencies - such as the DOD and VA - from purchasing this unsafe device; and
  • Introducing new legislation to eliminate the blanket civil liability protections that device manufacturers like Bayer currently receive for a non-life-saving device like Essure because those harmed deserve a voice in court.

Simply put, it’s time for Congress and the FDA to get serious about reforming medical device safety laws.”

Fitzpatrick has been the leading voice in Congress calling for removal of Essure from the market – introducing the E-Free Act in November of 2015. Ahead of the FDA’s report, Fitzpatrick wrote to the agency urging them to consider possible inconsistencies in the number of fetal deaths caused by the device and also legal complaints alleging illegal kickbacks.

More than 25,000 women reported symptoms including extreme pelvic and abdominal pain, migraines, loss of teeth and hair, and the coil cutting into the uterus and other organs in the abdominal cavity. 10,000 have filed formal complaints with the FDA.

Read More

Terror Financing Task Force Holds First Hearing of 2016

2016/02/04

WASHINGTON, D.C. – Chairman Mike Fitzpatrick (R-PA) and Ranking Member Stephen F. Lynch (D-MA) together held the first hearing of the newly-reauthorized Task Force to Investigate Terrorism Financing Wednesday focused on trade-based money laundering.

Trade-based money laundering has been widely recognized as the most common form of money laundering and value transfer method utilized by crime and terrorist organizations, allowing these groups the ability to move billions of dollars annually virtually undetected. Given the considerable volume of international trade and the value of the transactions, the effects of trade-based money laundering can result in extensive repercussions for global commerce and government revenues. In response, the Department of Homeland Security established the first Trade Transparency Unit (TTU) in 2004 to examine anomalies and financial irregularities in trade data to identify instances of trade-based money laundering and customs fraud.

“In an increasingly connected world, trade-based money laundering allows terror and criminal syndicates to disguise their billions of dollars annually through the use of trade transactions in an attempt to legitimize their illicit origins. This cannot be allowed to continue,” said Fitzpatrick. “Building on what we know and have learned, this session of the task force will take a much closer look at this process as well as investigate several lesser known methodologies mentioned in previous hearings, including terror funding streams from Latin America, developing our regional partners’ capabilities to combat terror financing and the funding of foreign based terrorists.”

“With the complexity and rapid growth of international trade, there is ample opportunity for terrorist financers and criminal organizations to exploit the global financial system and engage in trade-based money laundering with low risk of being caught. We must increase transparency in the global trade network in order to increase the ability of the Financial Action Task Force (FATF) and other organizations to investigate this illicit money laundering and to halt this revenue source for terrorist organizations,” said Lynch. “I look forward to working closely with Chairman Fitzpatrick and our colleagues to address this critical issue and other potential vulnerabilities in the global financial system during the new session of the Task Force to Investigate Terrorism Financing.”

Testifying at the hearing were:

  • Mr. John Cassara, former U.S. Intelligence Officer and Treasury Special Agent

  • Mr. Louis Bock, former Senior Special Agent, U.S. Customs and Border Protection

  • Mr. Farley Mesko, Co-Founder and Chief Executive Officer, Sayari Analytics

  • Dr. Nikos Passas, Professor of Criminology and Criminal Justice, College of Social Sciences and Humanities, Northeastern University

“[The Department of Homeland Security] has neither the customs nor financial expertise to make the [Trade Transparency Unit] initiative a success. The loser here is our ability to tackle trade-based money laundering and tax revenue loss on a grand scale along with a missed opportunity to target funding flowing to terrorist targets such as ISIS which, of necessity, do participate in global trade,” said Bock.

Key Takeaways from the Hearing:

  • The Department of the Treasury, citing Immigration and Customs Enforcement information, has described trade-based money laundering as capable of laundering billions of dollars annually.

  • Key characteristics of the international trade system make it both attractive and vulnerable to illicit exploitation, including the enormous volume of trade, the complexity of foreign exchange transactions, and the limited ability to exchange customs data between countries.

  • Although trade-based money laundering is widely recognized as one of the most common manifestations of international money laundering, it appears to be less understood among policymakers than traditional forms of money laundering.

On Monday, the Drug Enforcement Agency (DEA) announced arrests targeting Lebanese Hizballah’s External Security Organization Business Affairs Component (BAC), which is involved in international criminal activities such as drug trafficking and drug proceed money laundering. The proceeds from illicit drug sales are laundered internationally and used to purchase weapons for Hizballah’s involvement in Syria. As the DEA notes, this multi-national investigation “spans the globe… and once again highlights the dangerous global nexus between drug trafficking and terrorism.” 

Building on previous findings, the task force will continue to hold hearings with U.S. terror financing officials and global counterterrorism experts to identify weaknesses in current policy, while working to ensure terror groups are unable to financially support their operations. 

Read More

GOP Lawmaker Asks FDA for Criminal Inquiry Into J&J Device

2016/01/12


Open letter to the president: a call for cooperation

2016/01/12


Local lawmakers at center of fight for conservation funding

2016/01/12


Loading legislation ... one moment please
Loading votes ... one moment please

Contact Information

2400 Rayburn HOB
Washington, DC 20515
Phone 202-225-4276
Fax 202-225-9511
fitzpatrick.house.gov

Committee Assignments

Financial Services

Congressman Mike Fitzpatrick is a lifelong resident of Bucks County, where he has been an active member of his community for decades.  In the 113th Congress, Mike’s number one priority is job creation.  Mike recognizes that government does not create jobs, but fosters an environment in which the private sector can create permanent, family sustaining jobs.

Mike graduated from Bishop Egan High School in Fairless Hills and earned his bachelor’s degree while working his way through St. Thomas University in Miami, Florida. Upon graduation, Mike was awarded the university’s highest service award.

Following graduation, Mike returned to Pennsylvania and in 1988, he graduated from Penn State’s Dickinson School of Law. While attending law school Mike was the Business Manager of the Dickinson Journal of International Law.  Mike is admitted to practice law in both Pennsylvania and New Jersey.

In 1995, Mike was appointed to the Bucks County Board of Commissioners where he served for ten years.  As a Bucks County Commissioner Mike was a champion of responsible county social service programs, job creation and efficient government administration.  He fought to preserve over 11,000 acres of beautiful farmland, parkland and critical natural areas. His record on open space earned him recognition from a variety of environmental organizations, including the Greenspace Alliance.

During his time as Commissioner, Mike led the fight to establish the county’s first Enterprise Zone, a project that eventually led to the creation of over 4,000 private sector jobs in Bucks County.

As a Member of the 109th Congress Mike demonstrated himself to be an independently- minded advocate for his constituents. He fought for stronger borders, lower taxes and smaller budget deficits. Locally he worked successfully to bring the National Veterans’ Cemetery to Bucks County.  Mike was also instrumental in flood mitigation efforts along the Neshaminy Creek watershed, which had been plagued by persistent flooding.

Mike returned to Congress in 2011 after practicing law in Bucks County focusing on representing small businesses and local governments.

Mike and his wife Kathy have been married twenty-four years and have six children – three girls (Katie, Maggie and Molly) and three boys (Jimmy, Mick and Tommy). An Eagle Scout, Mike has remained active in Scouting and is a past-President of the Bucks County Council of the Boy Scouts of America.


Serving With

Mike Kelly

PENNSYLVANIA's 3rd DISTRICT

Scott Perry

PENNSYLVANIA's 4th DISTRICT

Glenn Thompson

PENNSYLVANIA's 5th DISTRICT

Ryan Costello

PENNSYLVANIA's 6th DISTRICT

Patrick Meehan

PENNSYLVANIA's 7th DISTRICT

Bill Shuster

PENNSYLVANIA's 9th DISTRICT

Tom Marino

PENNSYLVANIA's 10th DISTRICT

Louis Barletta

PENNSYLVANIA's 11th DISTRICT

Keith Rothfus

PENNSYLVANIA's 12th DISTRICT

Charlie Dent

PENNSYLVANIA's 15th DISTRICT

Joe Pitts

PENNSYLVANIA's 16th DISTRICT

Tim Murphy

PENNSYLVANIA's 18th DISTRICT

Recent Videos